Trial intelligence / Profile preview

HIP Trial: Management of Hypotension In Preterm Infants

NCT01482559Phase 3Terminated

Sponsor
University College Cork
Start
Feb 2015
Primary completion
Sep 2017
Modality
Small Molecules
Countries
5
01

Overview

Phase 3, randomised trial of dopamine in hypotension (2 arms), sponsored by University College Cork. Primary endpoints: Survival to 36 weeks postmenstrual age free of severe brain injury and Survival without moderate or serious disability as defined using consensus criteria for neurodevelopmental impairment at 2 years. Started Feb 2015; status: terminated.

02

Drugs

dopamine
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT01482559.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01482559.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call